155 related articles for article (PubMed ID: 16095148)
21. [X-linked hyper-IGM syndrome associated to sclerosing cholangitis and gallbladder neoplasm: clinical case].
Rodríguez C; Carrión F; Marinovic MA; Chávez E; Preisler J; Pooley F; Futatani T; Ochs HD
Rev Med Chil; 2003 Mar; 131(3):303-8. PubMed ID: 12790080
[TBL] [Abstract][Full Text] [Related]
22. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase.
Zhu Y; Nonoyama S; Morio T; Muramatsu M; Honjo T; Mizutani S
J Med Dent Sci; 2003 Mar; 50(1):41-6. PubMed ID: 12715918
[TBL] [Abstract][Full Text] [Related]
23. The structural basis of hyper IgM deficiency - CD40L mutations.
Thusberg J; Vihinen M
Protein Eng Des Sel; 2007 Mar; 20(3):133-41. PubMed ID: 17307885
[TBL] [Abstract][Full Text] [Related]
24. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
[TBL] [Abstract][Full Text] [Related]
25. Trans-splicing repair of CD40 ligand deficiency results in naturally regulated correction of a mouse model of hyper-IgM X-linked immunodeficiency.
Tahara M; Pergolizzi RG; Kobayashi H; Krause A; Luettich K; Lesser ML; Crystal RG
Nat Med; 2004 Aug; 10(8):835-41. PubMed ID: 15273748
[TBL] [Abstract][Full Text] [Related]
26. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
[TBL] [Abstract][Full Text] [Related]
27. Hyper-IgM syndrome: a case report.
Wang IJ; Wang SJ; Yan DC; Lin SJ; Chiang BL
J Microbiol Immunol Infect; 2003 Sep; 36(3):215-7. PubMed ID: 14582569
[TBL] [Abstract][Full Text] [Related]
28. Hyperimmunoglobulin syndrome due to CD40 deficiency: possibly the first case from India.
Mishra A; Italia K; Gupta M; Desai M; Madkaikar M
J Postgrad Med; 2015; 61(1):46-8. PubMed ID: 25511220
[TBL] [Abstract][Full Text] [Related]
29. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
[TBL] [Abstract][Full Text] [Related]
30. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
[TBL] [Abstract][Full Text] [Related]
31. X-linked hyper-IgM syndrome associated with Cryptosporidium parvum and Cryptococcus neoformans infections: the first case with molecular diagnosis in Korea.
Jo EK; Kim HS; Lee MY; Iseki M; Lee JH; Song CH; Park JK; Hwang TJ; Kook H
J Korean Med Sci; 2002 Feb; 17(1):116-20. PubMed ID: 11850600
[TBL] [Abstract][Full Text] [Related]
32. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
33. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia.
Rezaei N; Aghamohammadi A; Ramyar A; Pan-Hammarstrom Q; Hammarstrom L
Int Arch Allergy Immunol; 2008; 147(3):255-9. PubMed ID: 18594157
[TBL] [Abstract][Full Text] [Related]
34. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
[TBL] [Abstract][Full Text] [Related]
35. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
Sacco MG; Ungari M; Catò EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P
Cancer Gene Ther; 2000 Oct; 7(10):1299-306. PubMed ID: 11059686
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome.
Zhu X; Chung I; O'Gorman MR; Scholl PR
Clin Immunol; 2001 Jun; 99(3):334-9. PubMed ID: 11358428
[TBL] [Abstract][Full Text] [Related]
37. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency.
Kutukculer N; Moratto D; Aydinok Y; Lougaris V; Aksoylar S; Plebani A; Genel F; Notarangelo LD
J Pediatr; 2003 Feb; 142(2):194-6. PubMed ID: 12584544
[TBL] [Abstract][Full Text] [Related]
38. [Hyper-IgM syndrome in members of two unrelated Chilean families: molecular and mutation analysis].
Luttges PD; Retamal DF; Spencer MY; Carrión FA; Valenzuela VM; Navarro SV; De Cornejo ML
Rev Med Chil; 2004 Oct; 132(10):1179-88. PubMed ID: 15631205
[TBL] [Abstract][Full Text] [Related]
39. X-linked hyper IgM syndrome: a report of the first case in Thailand with a confirmed mutation of CD40 ligand gene.
Santadusit S; Visitsunthon N; Ochs HD; Vichyanond P
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):165-8. PubMed ID: 11270473
[TBL] [Abstract][Full Text] [Related]
40. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome.
Kato T; Tsuge I; Inaba J; Kato K; Matsuyama T; Kojima S
Bone Marrow Transplant; 1999 May; 23(10):1081-3. PubMed ID: 10373076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
